Premier Alternatives

Kardigan

Drug Discovery · South San Francisco, CA · Founded 2023 · Privately Held (backing)

Operator of a heart health company intended to modernize cardiovascular drug development. Kardigan is based in South San Francisco, CA and was founded in 2023. It is valued at about $646 million as of Oct 2026, set by institutional fund marks. It has raised $554 million across 1 recorded round; the latest was a $254 million Series B in Oct 2025.

PMV mark · valuation
$646.0M
Oct 2026
Priced at
—
Total raised
$554.0M
Last round
Early Stage VC (Series B)
Oct 2025

Kardigan key facts

as of Oct 2026
  • Operator of a heart health company intended to modernize cardiovascular drug development.
  • Kardigan is valued at approximately $646.0M as of Oct 2026, per PrivateMarketView’s mark.
  • It has raised $554.0M across 1 recorded rounds; the latest was Early Stage VC (Series B) ($254.0M) in Oct 2025.
  • Notable investors include Fidelity Management & Research Company, ARCH Venture Partners, T. Rowe Price Group, Perceptive Advisors, Sequoia Heritage — 7 tracked in total.
  • 2 institutional filers report fund marks on Kardigan across 6 filings.
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$646.0M

Reported valuation; nothing comparable since.

set by institutional fund marksas of Oct 2026question about this number?
Free account
More of Kardigan with a free account
  • ·Watch Kardigan: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Institutional fund marks on Kardigan

2 filers · latest Jul 2026

2 SEC-registered funds reported 6 fair-value marks on Kardigan between Nov 2025 and Jul 2026. Filer-level marks and implied $/share are available to Pro members.

Unlock 6 fund marks

Membership and data by Private Market View

Every name the funds mark, next to where it trades →

Kardigan funding rounds

1 rounds
Oct 2025Early Stage VC (Series B)$254.0M▮
Full funding history →

Kardigan valuation

Kardigan is valued at approximately $646 million as of Oct 2026. The figure is set by institutional fund marks.

Recent activity

In the last 90 days, Kardigan's record added 3 institutional fund marks (latest period Jul 2026).

How much has Kardigan raised?

Kardigan has raised $554 million in total; 1 of its rounds is on record. The largest on record was a $254 million Series B in Oct 2025.

Institutional holders and vehicles

2 SEC-registered funds reported 6 fair-value marks on Kardigan between Nov 2025 and Jul 2026, in their N-PORT filings. Filer-level marks and implied per-share values are available to Pro members.

Kardigan investors

7 investors are on record for Kardigan, including Fidelity Management & Research Company, ARCH Venture Partners, T. Rowe Price Group and Perceptive Advisors. The Series B in Oct 2025 drew 3 investors.

Comparable companies

Comparable drug discovery names by valuation on PrivateMarketView: Abcuro ($700 million), Candid Therapeutics ($657 million) and VeraDermics (NYS: MANE) ($596 million).

About Kardigan

Operator of a heart health company intended to modernize cardiovascular drug development. The company specializes in matching critical disease drivers with treatment responders identified in clinical trials, enabling patients to have access to medicines that will cure their diseases.

Industry
Drug Discovery
Sector
Healthcare
HQ
South San Francisco, CA, United States
Founded
2023
Employees
135
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.